MICAD - Molecular Imaging and Contrast Agent Database
MICAD is a key component of the NIH Roadmap; it is developed by the National Center for Biotechnology
Information (NCBI), at the National Institutes of Health (NIH).
124I-T84.66 minibody:124I-T84.66 minibody has been developed for positron emission tomography (PET) imaging of CEA expression in tumors... More...
[18F]FB-NH-mini-E{E[c(RGDyK)]2}2 ([18F]FPRGD4):18FPRGD4 is an integrin-targeted molecular imaging agent developed for PET imaging of tumor vasculature ad angiogenesis...More...